• Analyst coverage
  • Consensus
  • Discover more
Component content

Analyst coverage
Below are listed the sell-side analysts that cover Givaudan on a regular basis.

INSTITUTIONNAMERECOMMENDATIONDATE
ABN AMRO - ODDO BHF B.V.Stefano Toffanoneutral21-03-2025
Baader HelveaCurrently no coverage  
Bank of AmericaMatthew Yatesbuy11-06-2025
BarclaysAlex Sloaneequal-weight08-07-2025
Berenberg BankFulvio Cazzolbuy17-02-2025
BNP Paribas ExaneNicola Tangneutral01-04-2022
CICVirginie Royere Roumagebuy15-09-2025
Citi Investment ResearchRanulf Orrneutral17-10-2024
Davy ResearchCathal Kennyoutperform09-09-2025
Deutsche BankVirginie Boucher-Fertéhold21-04-2021
DZ Bank AGThomas Maulhold04-07-2024
Goldman Sachs InternationalGeorgina Fraserbuy26-03-2024
JefferiesChris Counihanhold16-09-2025
J.P. MorganCeline Pannutioverweight27-01-2025
Kepler CheuvreuxPatrick Roquasbuy29-08-2024
Morgan StanleyLisa De Neveunderweight22-11-2023
MorningstarDiana Raduunderperformn.a.
Rothschild & Co RedburnArtem Chubarovneutral01-02-2024
Research PartnersEugen Pergerbuy12-04-2024
UBSCharles Edenneutral18-04-2024
Van Lanschot KempenEric Wilmerhold30-07-2025
VontobelArben Hasanajbuy15-04-2022
Zürcher KantonalbankDaniel Buerkioutperform18-07-2016
Consensus
Component content

Consensus
The consensus forecasts, compiled by Givaudan, are based on emails and reports received between 10 and 24 September 2025.

Disclaimer:

The consensus forecast set out below results from regular research reports made by analysts currently covering Givaudan, as detailed in the list below. This list has been drawn up to the best of Givaudan’s knowledge but does not purport to be comprehensive of all institutions publishing financial research on Givaudan.

Any opinions, forecasts, estimates, projections or predictions regarding Givaudan’s performance made by the analysts are exclusively theirs and do not represent the opinions, forecasts, estimates, projections or predictions of Givaudan or its management. The publication of this information on this website does not imply that Givaudan endorses, or concurs with, the reports, conclusions or recommendations of the cited analysts. Givaudan disclaims any liability for the accuracy or completeness of such information and does not assume any obligation to update it even if it becomes aware of any changes.

This information is provided for ease of reference only and does not constitute an offer or solicitation to buy, hold or sell Givaudan securities.

in millions of Swiss francsFY 2024 AFY 2025 EFY 2026 E 9M 2024 A9M 2025 EQ3 2024 AQ3 2025 E
Group sales7,412   5,644 1,907 
- High 7,6347,984  5,791 1,927
- Average 7,517 7,759  5,745 1,881
- Low 7,4487,529  5,708 1,844
LFL Group sales growth (%)12.3%   13.0% 14.1% 
- High 5.6%6.0%  6.0% 5.3%
- Average 5.4%4.7%  5.5% 3.9%
- Low 4.8%3.5%  4.8% 1.6%
Fragrance & Beauty (F&B) sales3,660   2,782 956 
- High 3,8594,057  2,944 990
- Average 3,7973,917  2,906 951
- Low 3,7553,799  2,884 929
LFL F&B sales growth (%)14.1%   15.6% 16.0% 
- High 7.9%6.0%  9.1% 6.5%
- Average 7.0%4.6%  7.4% 4.7%
- Low 6.5%3.5%  6.5% 2.5%
Taste & Wellbeing (T&W) sales3,752   2,862 951 
- High 3,8193,934  2,864 954
- Average 3,7213,835  2,814 927
- Low 3,6713,713  2,434 899
LFL T&W sales growth (%)10.7%   10.7% 12.4% 
- High 4.5%6.5%  4.4% 4.2%
- Average 3.7%4.8%  3.7% 3.1%
- Low 1.7%3.5%  0.8% -1.2%
 
Comparable EBITDA Group1,816    
- High  1,8882,009  
- Average  1,8481,904  
- Low 1,8161,802  
Comparable EBITDA margin (%)24.5%    
- High 25.0%25.2%  
- Average 24.6%24.5%  
- Low 24.1%23.8%  
Fragrance & Beauty (F&B) sales1,017    
- High  1,0531,169  
- Average 1,0231,049  
- Low 977987  
F&B comp. EBITDA margin (%)27.8%    
- High 27.7%29.1%  
- Average 26.9%26.7%  
- Low 25.7%25.8%  
Taste & Wellbeing (T&W) sales799    
- High 847935  
- Average 826856  
- Low 801813  
T&W comp. EBITDA margin (%)21.3%    
- High 22.7%23.8%  
- Average 22.2%22.3%  
- Low 21.8%20.8%  
Reported EBITDA1,765    
- High 1,8371,962  
- Average 1,7961,888  
- Low 1,7381,782  
Reported EBITDA margin (%)23.8%    
- High 24.4%25.0%  
- Average 23.9%24.3%  
- Low 23.0%23.3%  
 
Net income reported 1,090    
- High 1,1591,208  
- Average  1,0891,163  
- Low 1,0071,058  
 
Free cash flow reported1,158    
- High  1,2631,378  
- Average 9821,098  
- Low 468947  
Free cash flow as a % of sales15.6%    
- High 16.9%17.4%  
- Average 13.1%14.2%  
- Low 6.2%12.6%  
 
Price target   
- High 4,800 
- Average4,028 
- Low3,300 
 
Recommendation  
Buy9 
Hold7 
Sell1 
 
Number of estimates17 
 
Latest update24-09-2025 

Note: numbers might not sum-up because of rounding.

Discover more
Component content